MetLife, Inc. MET
97.70
0.45
0.46%
as of 25 Sep
- Market cap
- $61.6B
- P/E
- 18.7×
Follow MET
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
16.21 | 13.71 | 16.80 | 15.51 |
+8 more quarters Free account |
P/S ratio |
0.68 | 0.59 | 0.69 | 0.76 | |
P/FCF ratio |
3.49 | 2.97 | 3.09 | 3.74 | |
P/Operating CF |
24.40 | 17.16 | 7.46 | 15.35 | |
P/B ratio |
1.96 | 1.67 | 1.84 | 1.88 | |
Price to Tangible BV |
2.99 | 2.56 | 2.77 | 2.72 | |
EV/Sales |
0.70 | 0.56 | 0.65 | 0.76 | |
EV/EBITDA |
11.34 | 9.08 | 10.75 | 11.12 | |
EV/Operating CF |
3.55 | 2.82 | 2.93 | 3.74 | |
EV/FCF |
3.55 | 2.82 | 2.93 | 3.74 | |
Quick Ratio |
0.15 | 0.15 | 0.15 | 0.13 | |
Current Ratio |
0.15 | 0.15 | 0.15 | 0.13 | |
Net Debt/EBITDA |
0.80 | (1.59) | (2.42) | 0.00 | |
Debt/Assets |
2.65% | 2.73% | 2.59% | 2.81% | |
Debt/Equity |
0.73 | 0.74 | 0.67 | 0.69 | |
Asset Turnover |
0.11 | 0.11 | 0.11 | 0.10 | |
Operating CF/Net income |
3.16 | 2.36 | 9.10 | 4.36 | |
Capex/Depreciation |
— | — | 0.00 | — | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.01 | 0.01 | 0.01 | 0.01 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Graham Net Nets |
(12.16) | (13.93) | (12.21) | (11.50) | |
Graham Number |
71.21 | 70.10 | 67.34 | 72.44 | |
Earnings Yield |
6.17% | 7.30% | 5.95% | 6.45% | |
Free Cash Flow Yield |
28.61% | 33.65% | 32.37% | 26.72% | |
Revenue per Share |
29.81 | 29.25 | 35.60 | 26.12 | |
Operating CF per Share |
3.47 | 4.12 | 10.58 | 5.37 | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
3.47 | 4.12 | 10.58 | 5.37 | |
Cash per Share |
30.04 | 34.80 | 32.94 | 30.44 | |
Shareholders Equity per Share |
43.17 | 42.32 | 42.88 | 43.92 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
43.17 | 42.32 | 42.88 | 43.92 | |
Free Cash Flow |
2,228.00 | 2,687.00 | 7,076.00 | 3,567.00 | |
Working Capital |
(409,993.00) | (401,837.00) | (401,303.00) | (401,392.00) | |
Net Current Asset Value |
(661,269.00) | (642,139.00) | (644,735.00) | (629,599.00) | |
EV/EBIT |
11.34 | 9.08 | 10.75 | 11.12 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
3.68% | 5.98% | 3.27% | 4.71% | |
Price to Operating Income |
11.17 | 9.58 | 11.33 | 11.12 | |
| Other line items | |||||
Average Receivables |
41,559.00 | 41,189.50 | 39,887.50 | 36,225.00 | |
Average Payables |
225,616.50 | 225,160.50 | 223,599.00 | 223,627.00 | |
Average Assets |
730,921.00 | 715,763.50 | 711,311.50 | 712,351.00 | |
Average Common Equity |
27,834.00 | 27,675.00 | 28,191.50 | 30,177.50 |
Columns are period end dates